Cargando…
Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo
BACKGROUND: Annual mass drug administrations (MDA) of ivermectin will strongly reduce Onchocerca volvulus microfilariae (mf) in the skin and in the onchocerciasis patients’ eyes. Ivermectin treatment will also affect the expression of immunity in patients, such that activated immune defenses may hel...
Autores principales: | Johanns, Saskia I., Gantin, Richard G., Wangala, Bawoubadi, Komlan, Kossi, Halatoko, Wemboo A., Banla, Meba, Karabou, Potchoziou, Luty, Adrian JF, Schulz-Key, Hartwig, Köhler, Carsten, Soboslay, Peter T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064110/ https://www.ncbi.nlm.nih.gov/pubmed/35503786 http://dx.doi.org/10.1371/journal.pntd.0010340 |
Ejemplares similares
-
Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin
por: Komlan, Kossi, et al.
Publicado: (2018) -
Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo
por: Korbmacher, Francois, et al.
Publicado: (2018) -
Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study
por: Banla, Méba, et al.
Publicado: (2014) -
Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis
por: Golden, Allison, et al.
Publicado: (2016) -
A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus
por: Golden, Allison, et al.
Publicado: (2016)